Brochure anxieté - version anglaise

Has

Description

ONLINE SPACE DEDICATED TO PRESCRIPTION TO PRESCRIPTION IMPROVEMENT IN THE EDERLY Y An online theme website dedicated to improving the prescription drug in the elderly, including psychotropic drugs, is available on www.has.sante.fr. This space provides health professionals and the public: - Key messages - Clinical experiences and tools for improvement practices - Reference texts PROGRAM 2007 - 2010 - Useful links “Improving the prescription of psychotropic drugs - Benchmark Figures in the French elderly” The specific program Psycho-SA (Psychotherapeutic and elderly) includes Anxiety aid targeted on situations leading to the prescription of psychotropic drugs including depression (cf. paragraph vocational programs). Guidelines and Appraisal step 2008 tools to stop benzodiazepines are available. There are also 4 clinical cases underlining the indications and difficulty of the BZD withdrawal and a memo on the motivational interview. For example, in the return of experience are the works of general practitioners on the cessation of benzodiazepines among older patients WHAT WE KNOW Signs of anxiety are a common reason for consulting among seniors. In fact, 2009 - 2010 TO BE CONTINUED... these signs often hide depression.

Sujets

• Médecine

Informations

• Publié par: haute-autorite-sante
• Nombre de lectures: 13
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique
• Langue: English

Extrait

O NLINE SPACE DEDICATED TO PRESCRIPTION TO PRESCRIPTION IMPROVEMENT IN THE EDERLY Y    An online theme website dedicated to improving the prescription drug in the elderly, including psychotropic drugs, is available on www.has.sante.fr. This space provides health professionals and the public:   -Key messages  -Clinical experiences and tools for improvement practices   Reference texts - -Useful links  -Benchmark Figures       The specific program Psycho-SA (Psychotherapeutic and elderly) includes aid targeted on situations leading to the prescription of psychotropic drugs including depression (cf. paragraph vocational programs). Guidelines and tools to stop benzodiazepines are available. There are also 4 clinical cases underlining the indications and difficulty of the BZD withdrawal and a memo on the motivational interview.   For example, in the return of experience are the works of general practitioners on the cessation of benzodiazepines among older patients     2009   -   2010   T O BE CONTINUED ...        HAS wants to develop the professionals with programs targeted at stop tranquilizers to reduce significantly the consumption of these drugs in the elderly. This work will also be conducted with pharmacists faced with requests from patients. Monitoring the consumption of tranquilizers achieved by age groups will permit the measuring during the next two years the results of these interventions.     After the success of the first thematic meetings of HAS (28 May 2008) to "improve the prescription drug in the very old" with psychotropic drugs, a new national day of presentations and exchanges of experience among health professionals will be held in May 2009. This day is open to all. You may already subscribe by writing to this email address programmespilotes@has- sante.fr  

    Haute Autorité de santé – 2, avenue du Stade de France – 93218 SAINT-DENIS LA PLAINE CEDEX Tél. : [phone] – Fax : [phone] –wwwte.fr.has-san 

                 P ROGRAM 2007   -   2010   “Improving the prescription of psychotropic drugs   in the French elderly”       Anxi t e y       Appraisal step 2008           HAT WE KNOW  W   Signs of anxiety are a common reason for consulting among seniors. In fact, these signs often hide depression. In only 3 to 10% of cases, these signs are the expression of a characterized anxiety disorder (such as generalized anxiety disorder, for example) that is difficult to diagnose in daily practice.     Anxiety disorders characterized must be distinguished from normal anxiety and anxiety symptoms. They are defined according to the number, intensity and duration of symptoms, and emotional suffering or a marked impact on the patient's life. Source: "The proper usage of antidepressant drugs in the treatment of depressive disorders and anxiety disorders in adults, recommendations, AFSSAPS, October 2006